Major trial for Hard-to-Treat OCD halted
Disease control
Terminated
This study aimed to check the long-term safety of a drug called troriluzole when added to standard treatments for obsessive compulsive disorder (OCD). It involved 772 adults whose OCD symptoms did not fully improve with common medications. The trial was terminated, and its main g…
Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC